Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950170-25-016381
Filing Date
2025-02-07
Accepted
2025-02-07 16:41:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 8420
  Complete submission text file 0000950170-25-016381.txt   9882
Mailing Address C/O DIVERSA CORPORATION 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address
SHORT JAY M PHD (Filed by) CIK: 0001205375 (see all company filings)

Type: SCHEDULE 13G/A

Mailing Address 11085 TORREYANA ROAD SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SAN DIEGO CA 92121 858-558-0708
BioAtla, Inc. (Subject) CIK: 0001826892 (see all company filings)

EIN.: 851922320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91930 | Film No.: 25602512
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)